PeptideStack
5.2kquestions
20kanswers
220users

Has anyone independently verified a QSC a GLP-1 receptor agonist batch COA?

Asked 25 Jan 2026Modified 3 months agoViewed 7.6k times
10

Stated plainly: QSC · a GLP-1 receptor agonist.

This has the shape of a fact but I cannot find its origin.

What I found instead were three secondary sources all citing each other.

Has anyone verified this independently?

vendor-vetting
vendor-vetting

Evaluating a supplier on evidence rather than reputation: testing history across batches, whether certificates are batch-specific, how failures…

454 questions
coa
coa

Certificates of analysis: what fields a useful one carries, how to tell a real analytical report from a marketing document, batch and lot…

771 questions
batch-testing
batch-testing

Testing at the batch or lot level: sampling plans, how many vials from a lot need testing to say anything about the lot, and the difference…

910 questions
shareeditfollowflag
TH
askedthreadlock719k2825 Jan 2026

5 Answers

Accepted answer first, then by votes
69

Accepted answer

The short version: ask for the lot-specific certificate, check the method section, check the lot code ties to a vial, then spend a small amount and test it yourself.

Ask what happens if a result comes back outside specification. The answer is informative regardless of what it is, and the question itself tells you something about how it lands.

Certificate red flags and what each implies

ObservationImplicationHow to check
Lot number not on the vialCertificate cannot be tied to your materialPhotograph vial and certificate together
No method sectionThe number is not reproducibleRequest column, gradient, wavelength
Purity to two decimals, no chromatogramFalse precisionRequest the trace
Test date before manufacture dateCertificate belongs to a different lotCompare dates
Identical figures across lotsOne certificate reusedCompare two lots side by side
“Sterile filtered” with no sterility testProcess claim substituted for a resultAsk for the sterility report

Set your accept threshold before you see the result. Deciding after the number arrives is how thresholds become negotiable, and everybody does it unless they wrote it down first.

Published inter-laboratory comparisons of peptide purity routinely find spreads of half a per cent to a per cent on identical material, which sets a realistic expectation for agreement.

Write your accept threshold down before the result arrives.

shareimprove this answerflag
NO
answered · acceptednkem_obiora39k3823 Feb 2026
3I have kept every invoice and declaration, which I gather is the useful habit. – e_dziedzic 3 months ago
2Any view on whether two lots agreeing is worth more than one lot excelling? I think it is. – ilaria_bertone 28 days ago
add a comment
Sponsored

PeptideMeter - Independent Peptide Analytics

Aggregated, published test results and vendor ratings built from submitted batches. Methodology stated, dataset browsable, no listing fees.

Browse results
26

Answering this needs to know whether you have already ordered, because the pre-order checks and the post-arrival checks are different lists.

The pre-order sequence: request a lot-specific certificate for the exact line, check that it names a lot code rather than a batch family, check that it carries the column, gradient and detection wavelength, and check the analysis date is recent relative to the lot.

The part that matters: published third-party data on a named lot is worth more than any aggregate rating, because it is about a specific object rather than about an average of other people's objects.

Aggregate community ratings, including the one on this site, are opinion averages rather than measurements and should carry less weight than a single result on your own lot.

Match the code on the glass to the code on the certificate. Everything else is secondary.

shareimprove this answerflag
JW
answeredj_wierzbicki69k1487 Mar 2026
21

Start with one request that costs nothing — a lot-specific certificate for the material you would actually be shipped — and read what comes back rather than whether something comes back.

Independent submission costs a fraction of a mid-sized order at any of the services this community uses, and it converts an opinion into a number attached to your own material.

Repeat the exercise on a second lot months later. Lot-to-lot agreement is the property that actually predicts your next order, and it cannot be established from one submission.

Nothing here is medical advice, and research-use compounds are not approved for human use in any jurisdiction.

Small first order, independent submission, then scale. In that order.

edited 1 Apr 2026 by RP_C18 — added a caveat about sampling

shareimprove this answerflag
RC
answeredRP_C18105k34818 Mar 2026
17

Worth being precise here: a certificate without a method section is a claim rather than a measurement, and that distinction does most of the work here.

The single most informative free test is asking for the certificate of the lot they intend to ship and then confirming, on arrival, that the code on the glass matches it. A supplier who can do that has a traceability system; one who cannot does not.

Two lots agreeing is worth more than one lot excelling.

shareimprove this answerflag
FU
answeredforty_units16k1729 Mar 2026
15

The honest answer is that a small first order tested independently beats any amount of reading, and it costs less than most people expect.

The post-arrival sequence: inspect before reconstitution, photograph anything unexpected, confirm the lot code is physically on the vial, and submit a sample to an independent laboratory before committing to a larger order.

Testing narrows uncertainty. It does not turn research-grade material into something with release testing behind it.

Ask for the lot-specific certificate before ordering. It is free and it is decisive.

shareimprove this answerflag
KA
answeredkwn_analytical147k35810 May 2026

Your answer

Ask PeptideStack is a static archive. Posting is closed, but the norms are worth stating: answer the question that was asked, show your working, cite the trial or the certificate, and say plainly where the evidence runs out.

Not medical advice. Research-use-only compounds are not approved for human use.